Article Text
Statistics from Altmetric.com
Reddel HK, Gerhardsson de Verdier M, Agustí A, et al. P138 An innovative approach to study design: using electronic medical records to inform the feasibility and design of the novelty study (a novel observational longitudinal study on patients with asthma and/or COPD). Thorax 2016;71:A157–A158. doi:10.1136/thoraxjnl-2016-209333.281
The affiliations for some authors has been corrected. The changes are indication in bold:
HK Reddel1, M Gerhardsson de Verdier2, A Agustí3, R Beasley4, EH Bel5, C Janson6, B Make7, RJ Martin7, I Pavord8, D Postma9, D Price10, C Keen2, A Gardev11, S Rennard11, A Sveréus2, AT Bansal12, L Brannman13, N Karlsson2, J Nuevo14, F Nyberg2, S Young11, J Vestbo15
1Woolcock Institute of Medical Research, Sydney, Australia
2AstraZeneca, Madrid, Spain
3Hospital Clinic University of Barcelona, Barcelona, Spain
4Medical Research Institute of New Zealand, Wellington, New Zealand
5Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
6Uppsala University, Uppsala, Sweden
7National Jewish Health and University of Colorado, Denver, USA
8University of Oxford, Oxford, UK
9University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
10Research in Real-Life, Singapore, Singapore
11AstraZeneca, Cambridge, UK
12Acclarogen Ltd, Cambridge, UK
13AstraZeneca, Gaithersburg, MD, USA
14AstraZeneca, Madrid, Spain
15The University of Manchester, Manchester, UK
Linked Articles
- Disease Progression and Burden in Obstructive Lung Disease